U.S. company wins first-ever approval of Ebola vaccine (November 26)   The U.S. pharmaceutical firm Merck & Co. has won the first-ever regulatory approval of a vaccine against the Ebola virus, a major boon in the fight against the deadly disease. The European Commission’s November 10 decision granting a significant step toward full approval of ... Read More»